Domov › Rakovina pľúc › Washington

Klinické štúdie Rakovina pľúc v štáte Washington

43 štúdií pre Rakovina pľúc hľadá účastníkov v zariadeniach v štáte Washington.

Mestá v štáte Washington

Oficiálny text štúdie (anglicky)

Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])

Valley Medical Center, Renton

Prebieha náborFáza 3

Vek 18 a viac · Všetky pohlavia · Aktualizované 2. 10. 2026 · NCT04267848

The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)

University of Washington, Fred Hutchinson Cancer Center, Seattle

Prebieha náborFáza 1/2

Vek 12 a viac · Všetky pohlavia · Aktualizované 2. 10. 2026 · NCT04585750

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

Providence Regional Cancer System-Aberdeen, Aberdeen
PeaceHealth Saint Joseph Medical Center, Bellingham
Providence Regional Cancer System-Centralia, Centralia
a 19 ďalších

Prebieha náborObservačná štúdiaVítaní zdravých dobrovoľníkov

Vek 40 až 75 · Všetky pohlavia · Aktualizované 2. 10. 2026 · NCT05334069

Chemotherapy Combined With Immunotherapy Versus Immunotherapy Alone for Older Adults With Stage IIIB-IV Lung Cancer, The ACHIEVE Trial

Swedish Cancer Institute-Edmonds, Edmonds
Swedish Cancer Institute-Issaquah, Issaquah
Swedish Medical Center-First Hill, Seattle

Prebieha náborFáza 3

Vek 70 a viac · Všetky pohlavia · Aktualizované 1. 10. 2026 · NCT06096844

Osimertinib With or Without Bevacizumab as Initial Treatment for Patients With EGFR-Mutant Lung Cancer

Kadlec Clinic Hematology and Oncology, Kennewick

Prebieha náborFáza 3

Vek 18 a viac · Všetky pohlavia · Aktualizované 1. 10. 2026 · NCT04181060

Open-Label Study of BBO-10203 in Subjects With Advanced Solid Tumors

Fred Hutchinson Cancer Center, Seattle

Prebieha náborFáza 1

Vek 18 a viac · Všetky pohlavia · Aktualizované 1. 10. 2026 · NCT06625775

Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-Small Cell Lung Cancer, INSIGHT Trial

Swedish Cancer Institute-Edmonds, Edmonds
Swedish Cancer Institute-Issaquah, Issaquah
Swedish Medical Center-First Hill, Seattle

Prebieha náborFáza 3

Vek 18 a viac · Všetky pohlavia · Aktualizované 1. 10. 2026 · NCT06498635

Neladalkib (NVL-655) for TKI-naive Patients With Advanced ALK-Positive NSCLC

University of Washington - Fred Hutchinson Cancer Center, Seattle
Compass Oncology, Vancouver

Prebieha náborFáza 3

Vek 18 a viac · Všetky pohlavia · Aktualizované 30. 9. 2026 · NCT06765109

Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer

Northwest Cancer Specialists, P.C., Vancouver

Prebieha náborFáza 3

Vek 18 a viac · Všetky pohlavia · Aktualizované 25. 9. 2026 · NCT07222566

A Study Evaluating Sotorasib Platinum Doublet Combination Versus Pembrolizumab Platinum Doublet Combination as a Front-Line Therapy in Participants With Stage IV or Advanced Stage IIIB/C Nonsquamous Non-Small Cell Lung Cancers (CodeBreaK 202)

Vista Oncology Inc PS, Olympia

Prebieha náborFáza 3

Vek 18 až 100 · Všetky pohlavia · Aktualizované 25. 9. 2026 · NCT05920356

This is a Study to Learn About How the Combination of the Study Medicines Sigvotatug Vedotin Plus Pembrolizumab Works in People With Non-small Cell Lung Cancer With High Levels of PD-L1.

American Oncology Network Vista Oncology Division-West office, Olympia
American Oncology Network Vista Oncology Division-East office, Olympia

Prebieha náborFáza 3

Vek 18 a viac · Všetky pohlavia · Aktualizované 25. 9. 2026 · NCT06758401

A Study to Evaluate the Safety, Tolerability, Drug Levels, and Preliminary Efficacy of BMS-986507 Combinations in Adult Participants With Advanced Solid Tumors

Swedish Medical Center, Seattle

Prebieha náborFáza 1/2

Vek 18 a viac · Všetky pohlavia · Aktualizované 23. 9. 2026 · NCT06618287

A Study to Compare the Combination of Navlimetostat (BMS-986504) With Pembrolizumab and Chemotherapy Versus Placebo Plus Pembrolizumab and Chemotherapy in First-line Metastatic Non-small Cell Lung Cancer Participants With Homozygous MTAP Deletion

Fred Hutchinson Cancer Center, Seattle

Prebieha náborFáza 2/3

Vek 18 a viac · Všetky pohlavia · Aktualizované 23. 9. 2026 · NCT07063745

Neoadjuvant and Adjuvant Treatment in Resectable Non-small Cell Lung Cancer

Research Site, Edmonds
Research Site, Seattle

Prebieha náborFáza 2

Vek 18 až 95 · Všetky pohlavia · Aktualizované 23. 9. 2026 · NCT05061550

Tailored Patient Navigation to Improve the Uptake of Lung Cancer Screening in Tribal Communities in Western Washington State, SACRED LUNGS Trial

Muckleshoot Tribal Clinic, Auburn
South Puget Intertribal Planning Agency (SPIPA), Shelton

Prebieha náborVítaní zdravých dobrovoľníkov

Vek 18 a viac · Všetky pohlavia · Aktualizované 21. 9. 2026 · NCT07176000

A Restorative Justice-Based Lung Cancer Screening Decision-Making Support Intervention Tailored for Black Individuals to Increase Lung Cancer Screening Among Black Community Members, RESTORE Trial

Fred Hutch/University of Washington Cancer Consortium, Seattle

Prebieha náborVítaní zdravých dobrovoľníkov

Vek 50 až 77 · Všetky pohlavia · Aktualizované 17. 9. 2026 · NCT07490860

Phase 1/2 Trial of S241656 in Selected RAS/MAPK Mutation- Positive Malignancies

Fred Hutchinson Cancer Research Center, Seattle

Prebieha náborFáza 1/2

Vek 18 a viac · Všetky pohlavia · Aktualizované 16. 9. 2026 · NCT05786924

A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer

Swedish Cancer Institute - Edmonds, Edmonds
Kadlec Clinic Hematology and Oncology, Kennewick
Swedish Medical Center, Seattle
a 2 ďalších

Prebieha náborFáza 3

Vek 18 a viac · Všetky pohlavia · Aktualizované 8. 9. 2026 · NCT06119581

AVENTINE-1: Study of AVZO-1418 as a Single Agent and in Combination Therapy in Patients With Locally Advanced or Metastatic Solid Tumors (AVZO-1418-1001)

Avenzo Therapeutics Recruiting Site, Seattle

Prebieha náborFáza 1/2

Vek 18 až 75 · Všetky pohlavia · Aktualizované 4. 9. 2026 · NCT07038343

Open-label Study of BBO-8520 in Adult Subjects With KRASG12C Non-small Cell Lung Cancer

Fred Hutchinson Cancer Center, Seattle
Northwest Medical Specialties, Tacoma

Prebieha náborFáza 1

Vek 18 a viac · Všetky pohlavia · Aktualizované 3. 9. 2026 · NCT06343402

The Vanguard Study: Testing a New Way to Screen for Cancer

Madigan Army Medical Center, Tacoma

Prebieha náborVítaní zdravých dobrovoľníkov

Vek 45 až 75 · Všetky pohlavia · Aktualizované 2. 9. 2026 · NCT06995898

Study to Evaluate Efficacy and Safety of Firmonertinib Compared With Investigator's Choice of EGFR Inhibitor as First-Line Treatment in Participants Who Have Locally Advanced or Metastatic NSCLC With EGFR P-Loop and Alpha C-Helix Compressing (PACC) Uncommon Mutations

Swedish Cancer Institute, Edmonds

Prebieha náborFáza 3

Vek 18 a viac · Všetky pohlavia · Aktualizované 1. 9. 2026 · NCT07185997

SX-682 and Atezolizumab for the Treatment of Advanced or Metastatic, Recurrent Non-small Cell Lung Cancer

Fred Hutch/University of Washington Cancer Consortium, Seattle

Prebieha náborFáza 2

Vek 18 a viac · Všetky pohlavia · Aktualizované 31. 8. 2026 · NCT07322341

Testing the Addition of High Dose, Targeted Radiation to the Usual Treatment for Locally-Advanced Inoperable Non-Small Cell Lung Cancer

Virginia Mason Medical Center, Seattle
Legacy Cancer Institute Medical Oncology and Day Treatment, Vancouver
Legacy Salmon Creek Hospital, Vancouver

Prebieha náborFáza 3

Vek 18 a viac · Všetky pohlavia · Aktualizované 17. 8. 2026 · NCT05624996

Hippocampal Avoidance in Craniospinal Irradiation for the Treatment of Leptomeningeal Metastases From Breast Cancer or Non-small Cell Lung Cancer

Fred Hutch/University of Washington Cancer Consortium, Seattle

Prebieha náborFáza 2

Vek 18 a viac · Všetky pohlavia · Aktualizované 14. 8. 2026 · NCT06518057

PET/CT Changes During Chemoimmunotherapy and Radiation Therapy in Patients With Stage IV Non-small Cell Lung Cancer

Fred Hutch/University of Washington Cancer Consortium, Seattle

Prebieha nábor

Vek 18 a viac · Všetky pohlavia · Aktualizované 6. 8. 2026 · NCT04151940

Study Evaluating the Safety and Efficacy of HWK-007, a PTK7-directed Antibody Drug Conjugate in Participants With Advanced Solid Tumors

Fred Hutchinson Cancer Center, Seattle

Prebieha náborFáza 1

Vek 18 a viac · Všetky pohlavia · Aktualizované 5. 8. 2026 · NCT07444814

Study of XmAb®819 in Subjects With Advanced Clear Cell Renal Cell Carcinoma

Xencor Investigative Site, Seattle

Prebieha náborFáza 1

Vek 18 a viac · Všetky pohlavia · Aktualizované 3. 8. 2026 · NCT05433142

Personalized Neo-Antigen Peptide Vaccine for the Treatment of Stage IIIC-IV Melanoma, Hormone Receptor Positive HER2 Negative Metastatic Refractory Breast Cancer or Stage III-IV Non-Small Cell Lung Cancer

Fred Hutch/University of Washington Cancer Consortium, Seattle

Prebieha náborFáza 1

Vek 18 a viac · Všetky pohlavia · Aktualizované 22. 7. 2026 · NCT05098210

A Study of Peluntamig (PT217) in Patients With Neuroendocrine Carcinomas Expressing DLL3 (the SKYBRIDGE Study)

Fred Hutch Cancer Center, Seattle

Prebieha náborFáza 1/2

Vek 18 a viac · Všetky pohlavia · Aktualizované 15. 7. 2026 · NCT05652686

Study of RAS(ON) Inhibitors in Patients With Advanced RAS-mutated NSCLC

Fred Hutchinson Cancer Research Center, Seattle

Prebieha náborFáza 1/2

Vek 18 a viac · Všetky pohlavia · Aktualizované 30. 6. 2026 · NCT06162221

Autologous LN-145 in Patients With Metastatic Non-Small-Cell Lung Cancer

Seattle Cancer Care Alliance, Seattle

Prebieha náborFáza 2

Vek 18 až 70 · Všetky pohlavia · Aktualizované 26. 6. 2026 · NCT04614103

SX-682 With Pembrolizumab for the Treatment of Metastatic or Recurrent Stage IIIC or IV Non-Small Cell Lung Cancer

Fred Hutch/University of Washington Cancer Consortium, Seattle

Prebieha náborFáza 2

Vek 18 a viac · Všetky pohlavia · Aktualizované 17. 6. 2026 · NCT05570825

A Study to Evaluate the Safety and Efficacy of Mesothelin-Targeting Logic-gated CAR T, in Participants With Solid Tumors That Express MSLN and Have Lost HLA-A*02 Expression

Fred Hutchinson Cancer Center, Seattle

Prebieha náborFáza 1/2

Vek 18 a viac · Všetky pohlavia · Aktualizované 12. 6. 2026 · NCT06051695

Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)

FHCC Overlake, Bellevue
FHCC at EvergreenHealth, Kirkland
Valley Medical Center, Renton
a 4 ďalších

Prebieha náborFáza 2

Vek 18 a viac · Všetky pohlavia · Aktualizované 3. 6. 2026 · NCT05642572

MYLUNG Consortium Part 3: Observational Study

Northwest Cancer Specialists, P.C., Vancouver

Prebieha náborObservačná štúdia

Vek 18 a viac · Všetky pohlavia · Aktualizované 18. 5. 2026 · NCT05885698

Study of RMC-6236 in Patients With Advanced Solid Tumors Harboring Specific Mutations in RAS

Virginia Mason Medical Center, Seattle

Prebieha náborFáza 1/2

Vek 18 a viac · Všetky pohlavia · Aktualizované 15. 5. 2026 · NCT05379985

Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has a MET Exon 14 Skipping Gene Change (An Expanded Lung-MAP Treatment Trial)

Swedish Cancer Institute-Edmonds, Edmonds
Swedish Cancer Institute-Issaquah, Issaquah
Swedish Medical Center-First Hill, Seattle

Prebieha náborFáza 2

18 Minutes · Všetky pohlavia · Aktualizované 5. 5. 2026 · NCT06031688

A Phase 1/2 Study of VS-7375 in Patients With KRAS G12D-Mutated Solid Tumors

Virginia Mason Medical Center, Seattle

Prebieha náborFáza 1/2

Vek 18 a viac · Všetky pohlavia · Aktualizované 22. 4. 2026 · NCT07020221

A Study of CLSP-1025 in Adult Patients With Solid Tumors That Harbor the p53 R175H Mutation

Fred Hutchinson Cancer Center, Seattle

Prebieha náborFáza 1

Vek 18 a viac · Všetky pohlavia · Aktualizované 13. 2. 2026 · NCT06778863

Z ClinicalTrials.gov, dáta načítané 5. 10. 2026. Každá štúdia má vlastné kritériá oprávnenosti; tím štúdie rozhoduje o účasti.